CLINICAL_TRIALS
trial_result
· 2023-10-11
Clinical Trial Update: 3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
Summary
Phase 2 clinical trial of 3K3A-APC for amyotrophic lateral sclerosis has completed; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Macquarie University, Australia | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2023-10-11